Author details

Full Name

Michael J Ross

Affiliation

ORCID

Career Start Year

2000

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37542267	The impact of non-pharmaceutical interventions on the first COVID-19 epidemic wave in South Africa.		2023
36356649	Viral associations with kidney disease diagnosis and altered kidney metatranscriptome by kidney function.	Kidney Int	2023
37598853	Association of HIV and viral suppression status with hospital acute kidney injury in the era of antiretroviral therapy.		2023
37224919	Editing of APOL1 mRNA reduces APOL1 expression and activation of innate immunity.		2023
32640015	The Impact of Immunosuppression on Chronic Kidney Disease in People Living With Human Immunodeficiency Virus: The D:A:D Study.	Journal of Infectious Diseases	2021
33912757	The Role of Glomerular Epithelial Injury in Kidney Function Decline in Patients With Diabetic Kidney Disease in the TRIDENT Cohort.	Kidney Int Rep	2021
34285421	Publisher Correction: A systems approach identifies HIPK2 as a key regulator of kidney fibrosis.	Nat Med	2021
34229329	Brief Report: Acute Kidney Injury in People Living With HIV Hospitalized With Coronavirus Disease 2019: Clinical Characteristics and Outcomes.	Journal of acquired immune deficiency syndromes (1999)	2021
34146599	Re-energizing the kidney: targeting fatty acid metabolism protects against kidney fibrosis.	Kidney International	2021
33930411	Use of peritoneal dialysis for acute kidney injury during the COVID-19 pandemic in New York City: a multicenter observational study.	Kidney Int	2021
32804611	Effect of Systemic Glucocorticoids on Mortality or Mechanical Ventilation in Patients With COVID-19.	J Hosp Med	2020
32132565	Publisher Correction: The HIV protease inhibitor darunavir prevents kidney injury via HIV-independent mechanisms.	Sci Rep	2020
31901339	Rationale and design of the Transformative Research in Diabetic NephropathyÂ (TRIDENT) Study.	Kidney Int	2020
32405595	Ritonavir-Boosted Protease Inhibitors Do Not Significantly Affect the Performance of Creatinine-Based Estimates of GFR.	Kidney International Reports	2020
32341009	The Feasibility and Safety of Obtaining Research Kidney Biopsy Cores in Patients with Diabetes: An Interim Analysis of the TRIDENT Study.	Clin J Am Soc Nephrol	2020
31317110	New Insights into APOL1 and Kidney Disease inÂ African Children andÂ Brazilians Living WithÂ End-Stage Kidney Disease.	Kidney International Reports	2019
31676833	The HIV protease inhibitor darunavir prevents kidney injury via HIV-independent mechanisms.	Sci Rep	2019
29198467	Using CRISPR to inactivate endogenous retroviruses in pigs: an important step toward safe xenotransplantation?	Kidney International	2018
29930940	Molecular Mechanisms of Injury in HIV-Associated Nephropathy.	Frontiers in Medicine	2018
28314574	APOL1: a case in point for replacing race with genetics.	Kidney Int	2017
28501298	ACE2 as therapy for glomerular disease: the devil is in the detail.	Kidney International	2017
28893419	Telenephrology: current perspectives and futureÂ directions.	Kidney International	2017
28492392	Predictors of estimated glomerular filtration rate progression, stabilization or improvement after chronic renal impairment in HIV-positive individuals.	AIDS	2017
28668686	Impact of early versus deferred antiretroviral therapy on estimated glomerular filtration rate in HIV-positive individuals in the START trial.	International Journal of Antimicrobial Agents	2017
28709608	APOL1 G2 risk allele-clarifying nomenclature.	Kidney International	2017
28790129	Perspectives on the Nephrology Match for Fellowship Applicants.	Clin J Am Soc Nephrol	2017
28003091	Recycling to discover something new: the role of autophagy in kidneyÂ disease.	Kidney International	2017
28202178	The Case \| Labile creatinine levels in a patient with breast cancer.	Kidney International	2017
26762990	Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study.	Lancet HIV,The	2016
26806826	Epithelial-to-mesenchymal transition of tubular epithelial cells in renal fibrosis: a new twist on an old tale.	Kidney International	2016
27418084	LAPping up dead cells to prevent lupus nephritis: a novel role forÂ noncanonical autophagy inÂ autoimmunity.	Kidney International	2016
26990086	Autophagy Limits Endotoxemic Acute Kidney Injury and Alters Renal Tubular Epithelial Cell Cytokine Expression.	PLoS ONE	2016
27485357	Renal Impairment and Cardiovascular Disease in HIV-Positive Individuals: The D:A:D Study.	Journal of Infectious Diseases	2016
26341128	Improving the Nephrology Match: the Path Forward.	J Am Soc Nephrol	2015
25711324	Kidney disease in antiretroviral-naÃ¯ve HIV-positive adults with high CD4 counts: prevalence and predictors of kidney disease at enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.	HIV Medicine	2015
25826420	Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.	PLoS Medicine	2015
25469847	Minimizing risks associated with renal replacement therapy in patients with Ebola virus disease.	Kidney Int	2015
26230200	Hepatitis C virus infection and kidney transplantation: newer options and a brighter future ahead?	Kidney International	2015
24827777	Advances in the pathogenesis of HIV-associated kidney diseases.	Kidney International	2014
25394023	A clinically useful risk-score for chronic kidney disease in HIV infection.	Journal of the International AIDS Society	2014
24361680	Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive persons.	AIDS	2014
24024499	Glomerular filtration rate estimated using creatinine, cystatin C or both markers and the risk of clinical events in HIV-infected individuals.	HIV Medicine	2014
24485030	Autophagy and immune response in kidneys.	Seminars in Nephrology	2014
25234519	Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.	Clin Infect Dis	2014
24666792	Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: the D:A:D study.	BMC Nephrology	2014
23382571	Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study.	Journal of Infectious Diseases	2013
22808988	Determinants of incident chronic kidney disease and progression in a cohort of HIV-infected persons with unrestricted access to health care.	HIV Medicine	2013
23842188	Podocyte-specific deletion of signal transducer and activator of transcription 3 attenuates nephrotoxic serum-induced glomerulonephritis.	Kidney International	2013
22406746	A systems approach identifies HIPK2 as a key regulator of kidney fibrosis.	Nat Med	2012
22911697	Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults.	PLoS ONE	2012